Article Details

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Consensus Recommendation of “Hold ...

Retrieved on: 2022-07-10 14:32:21

Tags for this article:

Click the tags to see associated articles and topics

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Consensus Recommendation of “Hold .... View article details on HISWAI: https://www.defenseworld.net/2022/07/10/esperion-therapeutics-inc-nasdaqespr-given-consensus-recommendation-of-hold-by-brokerages.html

Excerpt

Vanguard Group Inc. now owns 4,491,530 shares of the biopharmaceutical company's stock worth $20,841,000 after purchasing an additional 730,091 shares ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up